Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001493152-23-015519
Filing Date
2023-05-05
Accepted
2023-05-05 09:35:22
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-05-05

Document Format Files

Seq Description Document Type Size
1 formars.pdf ARS 1563131
  Complete submission text file 0001493152-23-015519.txt   2154321
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39318 | Film No.: 23891617
SIC: 2834 Pharmaceutical Preparations